2Schwartz M, Roayaie S, Konstadoulakis M. Strategies for the man- agement of hepatocellular carcinoma [ J ]. Nature Clinical Practice Oncology,2007,4(7) :424 -432.
3Tang W,Zhu J,Su S,et al. MiR -27 as a prognostic marker ibrbreast cancer progression and patient survival [ J ]. PLoS One, 2012,7(12) :e51702.
4Kao C J, Martiniez A, Shi XB, et al. miR - 30a as a tumor suppres- sor connects EGF/Src signal to ERG and EMT [ J 1. Oncogene, 2014,33 ( 19 ) :2495 - 2503.
5Markou A, Sourviou I, Vorkas PA, et al. Clinical evaluation of mi- croRNA expression profiling in non small cell lung cancer [ J ]. Lung Cancer,2013,81 (3) : 88 -96.
6Yau WL, Lam CS,Ng L,et al. Over- expression of miR- 106b promotes cell migration and metastasis in hepatocellular carcinoma by activating epithelial - mesenchymal transition process [ J ]. PloS One, 2013,8(3) :e57882.
7Zhang LY, Liu M, Li X, et al. miR-490-3p modulates cell growth and epithelial to mesenchymal transition of hepatocellular carcinoma cells by targeting endoplasmic reticulum - Golgi inter- mediate compartment protein 3 (ERGIC3)[J]. The Journal of Bi- ological Chemistly,2013,288 (6) :4035 -4047.
8Markou A, Sourvinou I, Vorkas PA, et al. Clinical evaluation of microRNA expression profiling in non small cell lung cancer[ J]. Lung Cancer, 2013,81 ( 3 ) : 88 - 96.
9Tang W,Zhu J,Su S, et al. MiR -27 as a prognostic marker for breast cancer progression and patient survival [ J ]. PLoS One, 2012,7(12) : e51702.
10Kao C J, Martiniez A, Shi XB, et al. miR - 30a as a tumor suppres- sor connects EGF/Src signal to ERG and EMT [ J ]. Oncogene, 2014, 33 (19) : 2495 - 2503.
